Abcuro, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-13.
Announced $66M on 2026-08-18; Form D shows $39.4M sold as of 2026-08-13. Announced vs filed
Abcuro, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 13, 2026. The filing reports $39.38M sold. Its industry group is Biotechnology. It names John Martin (Executive Officer, Director), Mark Pruzanski (Director), Ron Hunt (Director) (SEC Form D, August 13, 2026).
In its own words: “The determination of people living with inclusion body myositis inspires our work and strengthens our resolve to advance precision therapies with the potential to change what's possible.” (abcuro.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Abcuro, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Abcuro, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Abcuro, Inc.
Free to see. No signup.
More on the people and the money behind Abcuro, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in August 2026, largest first.
Get an email when Abcuro, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Abcuro, Inc. raises, hires or launches. No email unless you switch it on.
Watch Abcuro, Inc. →Get the full cited report on Abcuro, Inc.
What the filing shows about Abcuro, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Abcuro, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Abcuro, Inc.'s address as 55 Chapel St Suite 200, Newton, MA 02458.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Abcuro, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Abcuro, Inc. is a registered filer with the SEC (CIK 1692147) and has filed since 2023-08-25. 3 filings are on record, the latest on 2026-08-13.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Abcuro, Inc.'s Form D of 2026-08-13 names John Martin, Mark Pruzanski, Ron Hunt and 3 more as its officers, directors or promoters.
Its new offerings report $239.52M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $39.38M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
John Martin is named as Executive Officer and Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
Mark Pruzanski is named as Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
Ron Hunt is named as Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
Michael Dybbs is named as Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
Ming Fang is named as Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
Sarah Boyce is named as Director on the Form D that Abcuro, Inc. filed with the SEC on 13 August 2026, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2026-08-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Abcuro, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Abcuro, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Abcuro, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Abcuro, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Abcuro, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (abcuro.com).
Each opens in a new tab, filled in for Abcuro, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Boston raises, week of 2026-08-10 · Biotech raises, week of 2026-08-10 · Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/abcuro-inc-form-d-26000001